Blacksmith Medicines, Inc.
CAGE Code: 6XVV8
NCAGE Code: 6XVV8
Status: Active
Type: Commercial Supplier
Dun & Bradstreet (DUNS): 078884924
Summary
Blacksmith Medicines, Inc. is an Active Commercial Supplier with the Cage Code 6XVV8 and is tracked by Dun & Bradstreet under DUNS Number 078884924..
Address
3033 Science Park Rd Ste 270
San Diego CA 92121-1168
United States
Points of Contact
No Points of Contact...
Related Information
People who viewed this 'CAGE Code' also viewed...
Technet Jarecki Engineering Circle Intl Temple Ralph Corona Consulting Btg Technology Systems Quality Technology Services, Inc. P&D Consultants Inc. Nova Commercial Co Inc Precision Metal Products Co Frut Stix Co Div Of Lafayette Foods Lynx Systems Kjos Neil A Music Co Circle M Construction Lopez Dunn Ramirez And Associates Morton Equipment And Supply Company G G B Drywall Co Ocean Sensors Inc King Communications Compucom Systems Inc
Frequently Asked Questions (FAQ) for CAGE 6XVV8
- What is CAGE Code 6XVV8?
- 6XVV8 is the unique identifier used by NATO Organizations to reference the physical entity known as Blacksmith Medicines, Inc. located at 3033 Science Park Rd Ste 270, San Diego CA 92121-1168, United States.
- Who is CAGE Code 6XVV8?
- 6XVV8 refers to Blacksmith Medicines, Inc. located at 3033 Science Park Rd Ste 270, San Diego CA 92121-1168, United States.
- Where is CAGE Code 6XVV8 Located?
- CAGE Code 6XVV8 is located in San Diego, CA, USA.
Contracting History for CAGE 6XVV8 Most Recent 25 Records
- 75N93022C00060
- Fg-2101: A First-In-Class Lpxc Inhibitor For The Treatment Of Mdr Gramnegative Urinary Tract Infections.
- 16 Nov 2023
- Fg-2101: A First-In-Class Lpxc Inhibitor For The Treatment Of Mdr Gramnegative Urinary Tract Infections.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $4,712,500.00
- Department Of Health And Human Services (Hhs)
- 75N93022C00060
- Fg-2101: A First-In-Class Lpxc Inhibitor For The Treatment Of Mdr Gramnegative Urinary Tract Infections.
- 21 Sep 2022
- Fg-2101: A First-In-Class Lpxc Inhibitor For The Treatment Of Mdr Gramnegative Urinary Tract Infections.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $4,712,500.00
- Department Of Health And Human Services (Hhs)
- 75N93022C00060
- Fg-2101: A First-In-Class Lpxc Inhibitor For The Treatment Of Mdr Gramnegative Urinary Tract Infections.
- 12 May 2023
- Fg-2101: A First-In-Class Lpxc Inhibitor For The Treatment Of Mdr Gramnegative Urinary Tract Infections.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $4,712,500.00
- Department Of Health And Human Services (Hhs)